Article

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2: a population-based cohort analysis

2021-08-02

Abstract excerpt

<h4>Objectives</h4> To calculate the observed rates of thrombosis and thrombocytopenia following vaccination against SARS-CoV-2, infection with SARS-CoV-2, and to compare them to background (expected) rates in the general population. <h4>Design</h4> Cohort study using routinely collected primary care records. <h4>Setting</h4> Routine practice in the United Kingdom. <h4>Participants</h4> Two mutually exclusive vacc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: de0f8025-4138-54a6-ba5f-a7e9aacf1584
DOI: 10.1101/2021.07.29.21261348

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2: a population-based cohort analysisDOI 10.1101/2021.07.29.21261348Read

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 25.4 million people in six European countriesSemantic proximity Read

COVID-19 vaccine-associated cerebral venous thrombosis in GermanySemantic proximity Read

Arterial and Venous Thrombosis in COVID-19 Disease: From Molecular Pathway to Vaccine AdministrationSemantic proximity Read

Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study.Semantic proximity Read

COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?Semantic proximity Read

Background rates of hospitalizations and emergency department visits for selected thromboembolic and coagulation disorders in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillanceSemantic proximity Read

Impact of vaccination on the association of COVID-19 with arterial and venous thrombotic diseases: an OpenSAFELY cohort study using linked electronic health recordsSemantic proximity Read

Background Rates of 41 Adverse Events of Special Interest for COVID-19 Vaccines in 10 European Healthcare Databases - an ACCESS Cohort StudySemantic proximity Read

Background Rates of 41 Adverse Events of Special Interest for COVID-19 Vaccines in 10 European Healthcare Databases - An ACCESS Cohort StudySemantic proximity Read

Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review.Semantic proximity Read

Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling frameworkSemantic proximity Read

Venous and Arterial Thromboembolic Events after COVID-19 During the Omicron Period in three European countriesSemantic proximity Read